Longboard Pharmaceuticals, Inc. (LBPH) Tops Q3 EPS by 13c
Tweet
Share
E-mailGet Alerts LBPH Hot Sheet
Join SI Premium – FREE
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) reported Q3 EPS of ($0.55), $0.13 better than the analyst estimate of ($0.68).
For earnings history and earnings-related data on Longboard Pharmaceuticals, Inc. (LBPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Carvana (CVNA) PT Lowered to $85 at RBC Capital
- Dollarama Inc. (DOL:CN) (DLMAF) PT Raised to Cdn$221 at BMO Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
